Related Experiment Video For coexistent pulmonary tuberculosis and lung cancer
Updated: Sep 13, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Establishment and validation of a convenient and efficient screening tool for active pulmonary tuberculosis in lung
Fan Zhang1,2,3, Fei Qi1,4, Mengyan Sun5
1General Department, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Background:
Coexistent pulmonary tuberculosis and lung cancer (PTB-LC) is a rare type of disease with frequent under- and/or mis-diagnosis. Establishment of a reliable screening model for PTB-LC holds considerable medical and economic significance.
Objectives:
We aimed to develop an efficient and convenient tool to identify high-risk individuals for tuberculosis (TB) infection among LC patients based on commonly available parameters in clinical practice.
Design:
This study consisted of a primary retrospective patient cohort for model construction and verification, and a prospective patient cohort for prospective validation.
Methods:
Patients with active PTB-LC and LC diagnosed in Beijing Chest Hospital from 2018 to 2022 were collected and 1:1 matched according to time of admission and were classified into a training set (n = 281) and testing set (n = 121). Baseline information, clinicopathological features, imaging manifestations, and blood testing results were collected and analyzed. Five machine learning methods, including logistic regression (LR), random forest (RF), support vector machine (SVM), decision tree (DT), and neural network (NN), were employed to develop a screening model for PTB-LC.
Results:
Through multivariable analysis, gender, pleural effusion, cavitation, monocyte count (MONO), and plasma adenosine deaminase (ADA) levels were identified as independent predictors of PTB-LC and included in model construction. LR, RF, SVM, DT, and NN were used to construct the screening or pre-diagnosis models. The RF demonstrated the best performance with an area under the curve of 0.966 in the training set, 0.817 in the testing set, and 0.805 in the prospective dataset. The accuracy, precision, recall, and F1 score of the RF model of the training set were 0.88, 0.87, 0.89, and 0.88, respectively, and these indicators of the testing set were 0.71, 0.75, 0.72, and 0.74, respectively, which were superior to those of other methods. The prospective cohort further validated the good performance of the screening model. We also established a nomogram with gender, pleural effusion, cavitation, MONO, and serum ADA in assessing high-risk patients of developing TB infection. Further TB-related diagnostic tests were recommended for these high-risk patients.
Conclusion:
The RF screening model constructed with gender, pleural effusion, cavitation, MONO, and ADA may help identify high-risk patients of PTB-LC from LC alone cases.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...

